PubRank

B Heinze

Author PubWeight™ 43.81‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The genome of black cottonwood, Populus trichocarpa (Torr. & Gray). Science 2006 21.03
2 Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia. The German CML Study Group. Blood 1994 2.78
3 Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reaction. Lancet 1991 2.33
4 Barrier to gene flow between two ecologically divergent Populus species, P. alba (white poplar) and P. tremula (European aspen): the role of ecology and life history in gene introgression. Mol Ecol 2005 1.61
5 Improved outcome in adult B-cell acute lymphoblastic leukemia. Blood 1996 1.26
6 Randomized comparison of busulfan and hydroxyurea in chronic myelogenous leukemia: prolongation of survival by hydroxyurea. The German CML Study Group. Blood 1993 1.16
7 Immunophenotypic and genotypic features, clinical characteristics, and treatment outcome of adult pro-B acute lymphoblastic leukemia: results of the German multicenter trials GMALL 03/87 and 04/89. Blood 1998 1.08
8 Admixture in European Populus hybrid zones makes feasible the mapping of loci that contribute to reproductive isolation and trait differences. Heredity (Edinb) 2006 1.06
9 Rapid detection of radiation-induced chromosomal aberrations in lymphocytes and hematopoietic progenitor cells by mFISH. Mutat Res 2000 1.00
10 Chronic myelogenous leukemia in blast crisis: retrospective analysis of prognostic factors in 90 patients. Ann Hematol 1996 0.98
11 Stable chromosomal aberrations in haemopoietic stem cells in the blood of radiation accident victims. Int J Radiat Biol 1999 0.96
12 ALK gene products in anaplastic large cell lymphomas and Hodgkin's disease. Blood 1995 0.94
13 Detection of karyotypic aberrations in acute myeloblastic leukaemia: a prospective comparison between PCR/FISH and standard cytogenetics in 140 patients with de novo AML. Br J Haematol 1998 0.93
14 The translocation (6;9) (p23;q34) shows consistent rearrangement of two genes and defines a myeloproliferative disorder with specific clinical features. Blood 1992 0.90
15 Chronic myeloid leukemia in the elderly: long-term results from randomized trials with interferon alpha. Leukemia 2003 0.89
16 Karyotype abnormalities and their clinical significance in blast crisis of chronic myeloid leukemia. J Mol Med (Berl) 1998 0.88
17 Marrow fibrosis, indicator of therapy failure in chronic myeloid leukemia - prospective long-term results from a randomized-controlled trial. Leukemia 2003 0.88
18 Prospective BCR-ABL analysis by polymerase chain reaction (RT-PCR) in adult acute B-lineage lymphoblastic leukemia: reliability of RT-nested-PCR and comparison to cytogenetic data. Leukemia 2001 0.85
19 Interferon-alpha and donor buffy coat transfusions for treatment of relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation. Transplantation 1993 0.79
20 Detection of HRX-FEL fusion transcripts in pre-pre-B-ALL with and without cytogenetic demonstration of t(4;11). Leukemia 1994 0.77
21 Blast crisis of Philadelphia chromosome-positive chronic myelocytic leukemia (CML). Treatment results of 69 patients. Blut 1988 0.76
22 A phase I/II study of recombinant interferon alpha 2a and hydroxyurea for chronic myelocytic leukemia. Blut 1989 0.76
23 Molecular genetics: trees' genes and traits link up. Heredity (Edinb) 2008 0.75
24 New perspectives with interferon alpha. The German CML study group experience. Bone Marrow Transplant 1994 0.75
25 Evaluation of remission state in chronic myeloid leukemia patients after bone marrow transplantation using cytogenetic and molecular genetic approaches. Bone Marrow Transplant 1989 0.75
26 Chronic myeloid leukemia in accelerated phase: treatment results with conventional chemotherapy and allogeneic bone marrow transplantation in 96 patients. Eur J Haematol 1998 0.75
27 Influence of graft-versus-host disease on the eradication of minimal residual leukemia detected by polymerase chain reaction in chronic myeloid leukemia patients after bone marrow transplantation. Leukemia 1993 0.75
28 Chronic myelogenous leukemia: recent developments in prognostic evaluation and chemotherapy. The German CML Study Group. Leukemia 1992 0.75
29 German multicenter study group for adult ALL (GMALL): recruitment in comparison to ALL incidence and its impact on study results. Ann Hematol 2003 0.75
30 Pharmacopsychological effects of flunarizine in geriatric patients with light brainorganic psychosyndrome. Preliminary communication. Eur Neurol 1986 0.75
31 [Dependence of graphometric variables on anatomical and psychomotor characteristics]. Z Exp Angew Psychol 1973 0.75
32 The German CML study, comparison of busulfan vs. hydroxyurea vs. interferon alpha and establishment of prognostic score 1. Leuk Lymphoma 1993 0.75
33 Treatment intensity significantly influencing fibrosis in bone marrow independently of the cytogenetic response: meta-analysis of the long-term results from two prospective controlled trials on chronic myeloid leukemia. Leukemia 2004 0.75
34 [Leukocyte transfusion as therapy of recurrent CML after allogenic bone marrow transplantation]. Beitr Infusionsther Transfusionsmed 1994 0.75
35 Lymphocyte doses and chromosome aberrations in Chinese hamsters after injection of thorotrast and zirconotrast. Strahlentherapie Sonderb 1985 0.75
36 Relapse in chronic myeloid leukemia after bone marrow transplantation: biomathematical modeling as a new approach to understanding pathogenesis. Stem Cells 1999 0.75
37 Oncology patient identification system for application of management guidelines. Prog Clin Biol Res 1983 0.75
38 [Multicenter prospective controlled study of therapy of chronic myeloid leukemia. Comparison of busulfan, hydroxyurea and interferon alpha (April 1990 status)]. Onkologie 1991 0.75
39 Establishment and characterization of a new Epstein-Barr virus transformed cell line from a human B cell lymphoma. Blut 1990 0.75